Cargando…

Adjuvants and adjuvanticity

Adjuvants are added to vaccines to increase their potency. In general they do this by stimulating innate immune responses. They can be classified into damage-associated molecular patterns-type adjuvants that act by killing cells so that their released products trigger inflammation. Pathogen-associat...

Descripción completa

Detalles Bibliográficos
Autor principal: Tizard, Ian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348637/
http://dx.doi.org/10.1016/B978-0-323-68299-2.00016-2
_version_ 1783556874120986624
author Tizard, Ian R.
author_facet Tizard, Ian R.
author_sort Tizard, Ian R.
collection PubMed
description Adjuvants are added to vaccines to increase their potency. In general they do this by stimulating innate immune responses. They can be classified into damage-associated molecular patterns-type adjuvants that act by killing cells so that their released products trigger inflammation. Pathogen-associated molecular patterns-type adjuvants contain microbial molecules that trigger inflammation and dendritic cell maturation through pattern recognition receptors. A third type of adjuvant consists of nanoparticles or emulsions optimized to deliver antigen efficiently to dendritic cells or alternatively to prolong the release of antigen into the body. Different types of adjuvants may be combined to maximize their effect.
format Online
Article
Text
id pubmed-7348637
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-73486372020-07-10 Adjuvants and adjuvanticity Tizard, Ian R. Vaccines for Veterinarians Article Adjuvants are added to vaccines to increase their potency. In general they do this by stimulating innate immune responses. They can be classified into damage-associated molecular patterns-type adjuvants that act by killing cells so that their released products trigger inflammation. Pathogen-associated molecular patterns-type adjuvants contain microbial molecules that trigger inflammation and dendritic cell maturation through pattern recognition receptors. A third type of adjuvant consists of nanoparticles or emulsions optimized to deliver antigen efficiently to dendritic cells or alternatively to prolong the release of antigen into the body. Different types of adjuvants may be combined to maximize their effect. 2021 2020-07-10 /pmc/articles/PMC7348637/ http://dx.doi.org/10.1016/B978-0-323-68299-2.00016-2 Text en Copyright © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Tizard, Ian R.
Adjuvants and adjuvanticity
title Adjuvants and adjuvanticity
title_full Adjuvants and adjuvanticity
title_fullStr Adjuvants and adjuvanticity
title_full_unstemmed Adjuvants and adjuvanticity
title_short Adjuvants and adjuvanticity
title_sort adjuvants and adjuvanticity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348637/
http://dx.doi.org/10.1016/B978-0-323-68299-2.00016-2
work_keys_str_mv AT tizardianr adjuvantsandadjuvanticity